A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

Unique approach improves efficiency of conventional bone graft scanning process, reaching more patientsALACHUA, Fla., February 3, 2025 – Evergen ...

Health First Cardiothoracic Surgeon Seiichi Noda has vivid memories of his childhood, spending time with his father at the hospital where he worked as a neurosurgeon in Japan. Those visits had a ...

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

BANKING ...